Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001926257 | SCV002202651 | uncertain significance | Wilms tumor 1 | 2023-04-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 1422816). This variant has not been reported in the literature in individuals affected with GPC3-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects codon 58 of the GPC3 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the GPC3 protein. It affects a nucleotide within the consensus splice site. |
Fulgent Genetics, |
RCV005042528 | SCV005683306 | uncertain significance | Wilms tumor 1; Simpson-Golabi-Behmel syndrome type 1 | 2024-04-20 | criteria provided, single submitter | clinical testing |